Wu, Q., Qin, Y., & Li, Q. Cost-effectiveness of atezolizumab versus chemotherapy in patients with non-small-cell lung cancer ineligible for platinum-based doublet chemotherapy. Frontiers Media S.A.
Chicago Style (17th ed.) CitationWu, Qiuji, Yi Qin, and Qiu Li. Cost-effectiveness of Atezolizumab Versus Chemotherapy in Patients with Non-small-cell Lung Cancer Ineligible for Platinum-based Doublet Chemotherapy. Frontiers Media S.A.
MLA (9th ed.) CitationWu, Qiuji, et al. Cost-effectiveness of Atezolizumab Versus Chemotherapy in Patients with Non-small-cell Lung Cancer Ineligible for Platinum-based Doublet Chemotherapy. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.